help button home button Endocrine Society JCEM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a related Letter to the Editor
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Yoshida, T.
Right arrow Articles by Koshihara, Y.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Yoshida, T.
Right arrow Articles by Koshihara, Y.
The Journal of Clinical Endocrinology & Metabolism Vol. 86, No. 7 3272-3278
Copyright © 2001 by The Endocrine Society


Original Articles

Involvement of Prostaglandin E2 in Interleukin-1{alpha}-Induced Parathyroid Hormone-Related Peptide Production in Synovial Fibroblasts of Patients with Rheumatoid Arthritis

Tsuyoshi Yoshida, Hiroshi Sakamoto, Toshiyuki Horiuchi, Seizo Yamamoto, Ayako Suematsu, Hiromi Oda and Yasuko Koshihara

Department of Nutrition, Tokyo Metropolitan Institute of Gerontology (T.Y., A.S., Y.K.), Tokyo 173-0015, Japan; Sakamoto Clinic (H.S.), Kagoshima 899-73, Japan; Department of Internal Medicine (T.H.), Department of Orthopaedic Surgery (S.Y.), Tokyo Metropolitan Geriatric Hospital, Tokyo 173-0015, Japan; and Department of Orthopaedic Surgery, School of Medicine, University of Tokyo (H.O.), Tokyo 113-8655

Address all correspondence and requests for reprints to: Yasuko Koshihara, Ph.D., Department of Nutrition, Tokyo Metropolitan Institute of Gerontology, 35-2 Sakaecho, Itabashi-ku, Tokyo, 173-0015, Japan. E-mail: ykoshi{at}tmig.or.jp

Abstract

Synovial fibroblasts, established in culture from patients with RA, were treated with proinflammatory cytokines and prostaglandin E2 (PGE2) for 24 h. These cells enhanced the production and the messenger RNA expression of PTH-related peptide (PTHrP) using proinflammatory cytokines, such as interleukin (IL)-1{alpha}, tumor necrosis factor-{alpha} without the coordination of other cytokines. In addition, PGE2 which has been induced with IL-1, also enhanced the production of PTHrP. The IL-1{alpha}-induced PTHrP production was inhibited by PG H synthetase (Cox) inhibitors, indomethacin, and also by Cox-2 inhibitor, NS398. The synovial fibroblasts expressed PGE2 receptor subtypes, EP2, EP3, EP4, but not EP1, as detected by RT-PCR. Of the PGE2 receptor agonists, EP4 agonist showed the most marked induction of PTHrP, and EP2 agonist partly induced the production. However, these PGE2 receptors were not induced by the treatment with IL-1{alpha} and PGE2.

These results suggest that induction of PGE2 by IL-1{alpha} may be an important component of the PTHrP production of the inflammatory process in synovial tissues from patients with RA. These findings are the first to demonstrate that PGE2 stimulates PTHrP production, which is mediated mostly by EP2 and EP4 receptors.




This article has been cited by other articles:


Home page
J. Immunol.Home page
E. Kunisch, A. Jansen, F. Kojima, I. Loffler, M. Kapoor, S. Kawai, I. Rubio, L. J. Crofford, and R. W. Kinne
Prostaglandin E2 Differentially Modulates Proinflammatory/Prodestructive Effects of TNF-{alpha} on Synovial Fibroblasts via Specific E Prostanoid Receptors/cAMP
J. Immunol., July 15, 2009; 183(2): 1328 - 1336.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
P. Clark, S. E. Rowland, D. Denis, M.-C. Mathieu, R. Stocco, H. Poirier, J. Burch, Y. Han, L. Audoly, A. G. Therien, et al.
MF498 [N-{[4-(5,9-Diethoxy-6-oxo-6,8-dihydro-7H-pyrrolo[3,4-g]quinolin-7-yl)-3-methylbenzyl]sulfonyl}-2-(2-methoxyphenyl)acetamide], a Selective E Prostanoid Receptor 4 Antagonist, Relieves Joint Inflammation and Pain in Rodent Models of Rheumatoid and Osteoarthritis
J. Pharmacol. Exp. Ther., May 1, 2008; 325(2): 425 - 434.
[Abstract] [Full Text] [PDF]


Home page
Rheumatology (Oxford)Home page
D. E. Godler, A. N. Stein, O. Bakharevski, M. M. L. Lindsay, and P. F. J. Ryan
Parathyroid hormone-related peptide expression in rat collagen-induced arthritis
Rheumatology, September 1, 2005; 44(9): 1122 - 1131.
[Abstract] [Full Text] [PDF]


Home page
Ann Rheum DisHome page
R Largo, I Diez-Ortego, O Sanchez-Pernaute, M J Lopez-Armada, M A Alvarez-Soria, J Egido, and G Herrero-Beaumont
EP2/EP4 signalling inhibits monocyte chemoattractant protein-1 production induced by interleukin 1{beta} in synovial fibroblasts
Ann Rheum Dis, October 1, 2004; 63(10): 1197 - 1204.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 2001 by The Endocrine Society